gastroparesis glp 1 agonist New data links GLP-1 agonists for weight loss with higher risk for pancreatitis, GI events Our Pipeline - Neurogastrx, Inc.

GLP-1 medications such as Ozempic may help lower the risk of certain cancers.

Some Medicare patients will be able to access GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more...

Both glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter-2 (SGLT-2) inhibitors can reduce CV risk in patients with T2D, and both are recommended by the American Diabetes Association to reduce the risk of major cardiovascular events (MACE)

These compounds have demonstrated promise as natural glp 1 agonists and may complement dietary and lifestyle strategies for enhanced outcomes

Ozempic, Wegovy, Zepbound, and Mounjaro are GLP-1 medications that help lower blood sugar

Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.